Masco
MAS NYSE Building Products Financials FY2016βFY2025
Masco's revenue fell 3.4% to $7.6 billion in fiscal 2025. Its operating margin was 16.5%, down from 17.4% a year earlier. Free cash flow was $866 million, down 4.5%. It paid out $832 million in dividends and buybacks, 96% of free cash flow. The diluted share count fell 4.1%.
What Masco does
No business description yet.
- Legal name
- Masco Corporation
- Fiscal year ends
- December 31, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000062996-26-000005
0000062996
Revenue and margins
Masco had $7.6B of revenue in fiscal 2025, down 3.4% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 11.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $866M in fiscal 2025, 11.5% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Masco returned $832M to shareholders in fiscal 2025, 96% of free cash flow. The diluted share count fell 4.1%.
Value Masco yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$2.3B and divides by 210.0M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 18.9x Β· peers 18.6x Β· sector 26.0x.
Balance sheet
Cash, debt and the ratios that show how comfortably Masco can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $926M | $452M | $634M | $634M | $647M |
| Debt incl. finance leases | $3.0B | $3.2B | $3.0B | $3.0B | $3.0B |
| Net debt / EBITDA | 1.3x | 1.9x | 1.6x | 1.5x | 1.7x |
| Interest coverage | 5.1x | 12.0x | 12.7x | 13.8x | 12.4x |
| Current ratio | 1.8x | 1.6x | 1.7x | 1.8x | 1.8x |
| Quick ratio | 1.1x | 0.9x | 1.1x | 1.2x | 1.1x |
| Total assets | $5.6B | $5.2B | $5.4B | $5.0B | $5.2B |
| Total liabilities | $5.5B | $5.4B | $5.2B | $5.1B | $5.1B |
| Shareholders' equity | β$179M | β$480M | β$126M | β$279M | β$185M |
| Net debt (β = net cash) | $2.1B | $2.7B | $2.3B | $2.3B | $2.3B |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$5.1M
3 insiders
Of sales under plans
0%
$0.0M
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 8 / 9 | 6 / 9 | 7 / 9 |
| Accruals ratio | β9.6% | β4.9% | β4.2% |
| Altman Z'' | 2.77 | 2.89 | 2.79 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Masco MAS | $15.5B | β3.4% | 16.5% | 11.5% | 40.4% | 18.9x | 7 | |
| UFP Industries UFPI | $4.4B | β5.0% | 5.8% | 4.4% | 11.8% | 18.6x | 5 | Compare β |
| Owens Corning OC | $9.2B | 2.6% | 3.6% | 9.5% | 1.9% | β | 4 | Compare β |
| Lennox International LII | $13.2B | β2.7% | 20.1% | 12.3% | 40.1% | 16.7x | 5 | Compare β |
| Fortune Brands Innovations FBIN | $5.1B | β3.2% | 11.6% | 8.2% | 7.7% | 34.7x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $7.4B | $6.0B | $6.7B | $6.7B | $7.2B | $8.4B | $8.7B | $8.0B | $7.8B | $7.6B |
| Gross profit | $2.5B | $2.2B | $2.3B | $2.4B | $2.6B | $2.9B | $2.7B | $2.8B | $2.8B | $2.7B |
| Operating income | $1.1B | $1.0B | $1.1B | $1.1B | $1.3B | $1.4B | $1.3B | $1.3B | $1.4B | $1.2B |
| Interest expense | $229M | $279M | $156M | $159M | $144M | $278M | $108M | $106M | $99.0M | $101M |
| Pretax income | $832M | $718M | $907M | $914M | $1.1B | $688M | $1.2B | $1.2B | $1.2B | $1.1B |
| Income tax | $296M | $245M | $221M | $230M | $269M | $210M | $288M | $278M | $287M | $277M |
| Net income | $493M | $533M | $734M | $935M | $1.2B | $410M | $844M | $908M | $822M | $810M |
| Diluted EPS | $1.48 | $1.66 | $2.37 | $3.22 | $4.59 | $1.62 | $3.63 | $4.02 | $3.76 | $3.86 |
| Diluted shares | 0.33B | 0.32B | 0.31B | 0.29B | 0.26B | 0.25B | 0.23B | 0.23B | 0.22B | 0.21B |
| Cash flow | ||||||||||
| Cash from operations | $789M | $751M | $1.0B | $833M | $953M | $930M | $840M | $1.4B | $1.1B | $1.0B |
| Capital expenditure | $180M | $173M | $219M | $162M | $114M | $128M | $224M | $243M | $168M | $156M |
| Free cash flow | $609M | $578M | $813M | $671M | $839M | $802M | $616M | $1.2B | $907M | $866M |
| Depreciation and amortization | $134M | $127M | $156M | $159M | $133M | $151M | $145M | $149M | $150M | $148M |
| Stock-based compensation | $29.0M | $38.0M | $27.0M | $35.0M | $45.0M | $61.0M | $49.0M | $31.0M | $39.0M | $30.0M |
| Acquisitions | $0.0M | $89.0M | $549M | $0.0M | $227M | $57.0M | $0.0M | $136M | $4.0M | $0.0M |
| Share buybacks | $459M | $331M | $654M | $896M | $727M | $1.0B | $914M | $353M | $751M | $571M |
| Dividends paid | $128M | $129M | $134M | $144M | $145M | $211M | $258M | $257M | $254M | $261M |
| Dividends and buybacks | $587M | $460M | $788M | $1.0B | $872M | $1.2B | $1.2B | $610M | $1.0B | $832M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.2B | $1.3B | $552M | $697M | $1.3B | $926M | $452M | $634M | $634M | $647M |
| Total debt | $3.0B | $3.1B | $3.0B | $2.8B | $2.8B | $3.0B | $3.2B | $2.9B | $2.9B | $2.9B |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $30.0M | $28.0M | $26.0M | $23.0M | $20.0M | $17.0M | $14.0M |
| Current assets | $2.9B | $3.3B | $2.8B | $2.7B | $3.5B | $3.4B | $2.9B | $2.9B | $2.7B | $2.8B |
| Current liabilities | $1.5B | $1.7B | $1.7B | $1.5B | $1.9B | $1.9B | $1.9B | $1.7B | $1.6B | $1.6B |
| Inventory | $712M | $784M | $798M | $754M | $876M | $1.2B | $1.2B | $1.0B | $938M | $1.0B |
| Property and equipment, net | $1.1B | $1.1B | $885M | $878M | $908M | $896M | $975M | $1.1B | $1.1B | $1.2B |
| Total assets | $5.2B | $5.5B | $5.4B | $5.0B | $5.8B | $5.6B | $5.2B | $5.4B | $5.0B | $5.2B |
| Total liabilities | $5.2B | $5.4B | $5.3B | $5.1B | $5.4B | $5.5B | $5.4B | $5.2B | $5.1B | $5.1B |
| Shareholders' equity | β$298M | β$53.0M | β$111M | β$235M | $195M | β$179M | β$480M | β$126M | β$279M | β$185M |
| Margins | ||||||||||
| Gross margin | 33.5% | 36.9% | 35.0% | 35.4% | 36.0% | 34.2% | 31.3% | 35.6% | 36.2% | 35.4% |
| Operating margin | 14.8% | 17.1% | 16.2% | 16.2% | 18.0% | 16.8% | 14.9% | 16.9% | 17.4% | 16.5% |
| EBITDA margin | 16.6% | 19.2% | 18.5% | 18.6% | 19.9% | 18.6% | 16.6% | 18.8% | 19.3% | 18.5% |
| Net margin | 6.7% | 8.9% | 11.0% | 13.9% | 17.0% | 4.9% | 9.7% | 11.4% | 10.5% | 10.7% |
| FCF margin | 8.3% | 9.6% | 12.2% | 10.0% | 11.7% | 9.6% | 7.1% | 14.7% | 11.6% | 11.5% |
| Returns | ||||||||||
| Return on capital | 40.5% | 36.9% | 36.5% | 35.8% | 49.8% | 48.4% | 43.0% | 42.7% | 43.6% | 40.4% |
| Return on capital employed | 31.2% | 27.2% | 28.4% | 30.3% | 35.4% | 37.6% | 37.4% | 38.7% | 38.3% | 35.2% |
| Return on assets | 9.1% | 10.0% | 13.4% | 18.0% | 22.7% | 7.2% | 15.7% | 17.2% | 15.8% | 15.9% |
| Growth | ||||||||||
| Revenue growth | 3.1% | β18.3% | 10.6% | 0.8% | 7.2% | 16.5% | 3.6% | β8.2% | β1.7% | β3.4% |
| Net income growth | 38.9% | 8.1% | 37.7% | 27.4% | 30.9% | β66.5% | 105.9% | 7.6% | β9.5% | β1.5% |
| EPS growth | 45.1% | 12.2% | 42.8% | 35.9% | 42.6% | β64.7% | 124.1% | 10.7% | β6.5% | 2.7% |
| FCF growth | β6.6% | β5.1% | 40.7% | β17.5% | 25.0% | β4.4% | β23.2% | 89.9% | β22.5% | β4.5% |
| Share count change | β3.2% | β3.6% | β3.5% | β6.2% | β8.3% | β4.9% | β7.6% | β2.6% | β3.1% | β4.1% |
| Financial health | ||||||||||
| Net debt / EBITDA | 1.5x | 1.5x | 2.0x | 1.7x | 1.1x | 1.3x | 1.9x | 1.6x | 1.5x | 1.7x |
| Interest coverage | 4.8x | 3.7x | 6.9x | 6.8x | 9.0x | 5.1x | 12.0x | 12.7x | 13.8x | 12.4x |
| Current ratio | 2.0x | 2.0x | 1.6x | 1.8x | 1.8x | 1.8x | 1.6x | 1.7x | 1.8x | 1.8x |
| Quick ratio | 1.5x | 1.5x | 1.2x | 1.3x | 1.4x | 1.1x | 0.9x | 1.1x | 1.2x | 1.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 2.5% | 2.9% | 3.3% | 2.4% | 1.6% | 1.5% | 2.6% | 3.1% | 2.2% | 2.1% |
| Stock comp / revenue | 0.4% | 0.6% | 0.4% | 0.5% | 0.6% | 0.7% | 0.6% | 0.4% | 0.5% | 0.4% |
| Payouts / FCF | 96.4% | 79.6% | 96.9% | 155.0% | 103.9% | 154.2% | 190.3% | 52.1% | 110.8% | 96.1% |
| Quality scores | ||||||||||
| Piotroski F-score | 8.0 | 6.0 | 7.0 | 8.0 | 8.0 | 5.0 | 5.0 | 8.0 | 6.0 | 7.0 |
| Altman Z'' | 3.0 | 3.0 | 2.5 | 2.8 | 3.4 | 3.1 | 2.4 | 2.8 | 2.9 | 2.8 |
| Accruals ratio | β5.5% | β4.1% | β5.5% | 2.0% | 5.0% | β9.2% | 0.1% | β9.6% | β4.9% | β4.2% |
Source: SEC EDGAR XBRL filings (CIK 0000062996). Data updated October 9, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.